Page Comparison

CommCare has an evidence base of more than 75

peer-reviewed studies, including eight randomized controlled trials. Together, these studies demonstrate CommCare’s positive impact on strengthening frontline healthcare systems, frontline worker capabilities, and client results. Please note that several earlier studies included Dimagi staff, while the vast majority of later studies were done as third-party evaluations. This resource lives as an online, up-to-date repository, with new studies being shared and published frequently. Dimagi maintains the CommCare Evidence Base and adds new studies as they are discovered.

Within the CommCare Evidence Base,

two RCTs --  one in India and one in Tanzania -- demonstrate that clients of community health workers using CommCare have better behaviors and outcomes than the clients of community health workers who don’t use CommCare. An RCT by Mathematica Policy Research in India showed a 73% increase in having at least three antenatal care visits, a 58% increase in consuming 90 Iron-Folic Acid tablets, a 34% increase in modern contraceptives usage, and a 22% increase in immediate breastfeeding. (Borkhum, 2015). An RCT in Tanzania documented a 74% institutional delivery rate for clients whose FLWs use CommCare, compared to a 63% institutional delivery rate in the control group. [Hackett 2018]. Independent peer-reviewed cost effectiveness analysis determined that a scale-up of CommCare in Uttar Pradesh, India over a 10-year period would avert 149,468 neonatal deaths, at USD $205 per DALY averted and $5,865 per death averted. [Prinja 2018].

You can download the CommCare Evidence Base on Dimagi's Toolkits Page.